Department of Orthopaedic Surgery, The Fourth Military Medical University, Xijing Hospital, Xi'an, Shaanxi, China.
Spine (Phila Pa 1976). 2012 Dec 1;37(25):2104-13. doi: 10.1097/BRS.0b013e3182608988.
Retrospective clinical study.
The aim of this study was to evaluate retrospectively the safety and efficacy of 1-stage surgical treatment of 45 consecutive patients, who had progressive congenital spinal deformity associated with split spinal cord malformation (SSCM).
For correction of progressive congenital spinal deformity with SSCM, it has been reported that all SSCM should be operated on before any orthopedic intervention, and then surgery for correction and stabilization of the spinal deformity should be performed 3 to 6 months later. Recently, different viewpoints have been approved, and the common treatment of these 2 associated conditions needs to be re-evaluated.
Patients had 1-stage surgery. After exposure of the determined levels and placement of instruments, bony spur was resected in the patients of type 1; in patients of type 2, we did nothing to the SSCM. In the corrective stage of surgery, posterior fusion surgery was performed in 38 patients; nonfusion surgery was performed in 7 patients.
Thirty-six female patients and 9 male patients formed the basis of the study. The mean age was 14 years, and the mean follow-up period was 31 months. Type 1 SSCM was in 15 patients, and type 2 SSCM was in 30 patients. Seven patients had progressive neurological deteriorations preoperatively. The mean major curves were corrected from an average of 73.7° to 33.5°, with a correction rate of 54.5%. The overall complication was transient, including 2 patients of neurological compromise and 1 patient of cerebrospinal fluid leakage. The average loss of correction at final follow-up was 2.5° for major curves.
The 1-stage surgical treatment of congenital spinal deformity associated with SSCM provides a satisfactory option to improve the spinal deformity without significant complications effectively. Neurosurgical interventions are recommended to patients with type 1 SSCM before spinal deformity surgery; however, patients with type 2 SSCM can be treated safely without a need of neurosurgical intervention.
回顾性临床研究。
本研究旨在回顾性评估 45 例连续患者的 1 期手术治疗的安全性和有效性,这些患者患有进展性先天性脊柱畸形伴脊髓分裂畸形(SSCM)。
对于伴有 SSCM 的进行性先天性脊柱畸形的矫正,据报道,所有 SSCM 都应在任何矫形干预之前进行手术,然后在 3 至 6 个月后进行脊柱畸形矫正和稳定的手术。最近,已经批准了不同的观点,需要重新评估这两种相关疾病的共同治疗方法。
患者接受 1 期手术。在确定的水平暴露和器械放置后,在 1 型患者中切除骨嵴;在 2 型患者中,我们对 SSCM 不做任何处理。在手术矫正阶段,38 例患者行后路融合手术,7 例患者行非融合手术。
本研究共纳入 36 例女性患者和 9 例男性患者。平均年龄为 14 岁,平均随访时间为 31 个月。15 例患者为 1 型 SSCM,30 例患者为 2 型 SSCM。术前有 7 例患者出现进行性神经恶化。主要曲线的平均角度从平均 73.7°矫正至 33.5°,矫正率为 54.5%。整体并发症为一过性,包括 2 例神经功能障碍和 1 例脑脊液漏。最终随访时主要曲线的平均矫正丢失为 2.5°。
1 期手术治疗先天性脊柱畸形伴 SSCM 可有效改善脊柱畸形,且无明显并发症,是一种令人满意的选择。建议对脊柱畸形手术前存在 1 型 SSCM 的患者进行神经外科干预;然而,对于 2 型 SSCM 患者,可以安全地进行治疗,无需神经外科干预。